Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells.
Embryonic stem cells (ES) and induced pluripotent stem (iPS) cells represent promising tools for cell-based therapies and regenerative medicine. Nevertheless, implantation of ES cell derived differentiated cells holds the risk of teratoma formation due to residual undifferentiated cells. In order to...
Main Authors: | Tiong-Ti Lim, Caroline Geisen, Michael Hesse, Bernd K Fleischmann, Katrin Zimmermann, Alexander Pfeifer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3728319?pdf=render |
Similar Items
-
Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells
by: Franziska K. Geis, et al.
Published: (2017-05-01) -
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
by: Barbara Savoldo, et al.
Published: (2021-09-01) -
Thymidine Kinase+/− Mammalian Cell Mutagenicity Assays for Assessment of Nanomaterials
by: Tao Chen, et al.
Published: (2022-06-01) -
Generation of induced pluripotent stem cells by a polycistronic lentiviral vector in feeder- and serum- free defined culture
by: Al Abbar, Akram Faisal Mahmaud, et al.
Published: (2018) -
Generation of mouse induced pluripotent stem cells using polycistronic lentiviral vector in feeder - and serum-free culture
by: Mahmaud, Akram Faisal
Published: (2015)